Lu-177g is a low energy negatron emitter that thanks to its favourable decay properties (T1/2=6.734 d, negatron emission 100 %, E(beta,max)=489.3 keV, < E(beta) >=163 keV, E(gamma)=208.4 keV) is one of the most promising RNs to be used in nuclear medicine, especially in metabolic radiotherapy of cancer of small dimensions. The production of Lu-177g is carried out mainly in thermal nuclear reactor in two different ways by using targets of Lu or Yb: in the first case Lu-177(m+g) is produced in carrier-added (CA) form by (n,gamma) reaction on enriched target of Lu-176 leading to a lower specific activity AS compared to the theoretical carrier-free value AS(CF) = 4.05 GBq/microg, while in the second case Lu-177g is produced in no-carrier-added (NCA) form by (n,gamma) reaction on enriched target of Yb-176 followed by negatron decay leading, after selective separation of Lu from Yb, to a higher AS than in the previous case. This latter case shows no evidence of production of the long-lived impurity Lu-177m. As an alternative method is to produce Lu-177 by the deuteron activation of natural Yb or enriched in Yb-176 targets. In this case , with the following routs of interest are the indirect reaction Yb-176(d,p)Yb-177 that decays by negatron emission to Lu-177g and a much smaller contribution of the direct reaction Yb-176(d,n)Lu-177(g+m).

Production of high specific activity NCA Lu-177g by cyclotron irradiation / F. Groppi Garlandini, M. Bonardi, S. Manenti, A. Gandini, L. Gini. - In: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. - ISSN 0362-4803. - 52:S1(2009), pp. S374-S374. ((Intervento presentato al 18. convegno International symposium on radiopharmaceutical sciences tenutosi a Edmonton (Canada) nel 2009 [10.1002/jlcr.1646].

Production of high specific activity NCA Lu-177g by cyclotron irradiation

F. Groppi Garlandini;M. Bonardi;S. Manenti;
2009

Abstract

Lu-177g is a low energy negatron emitter that thanks to its favourable decay properties (T1/2=6.734 d, negatron emission 100 %, E(beta,max)=489.3 keV, < E(beta) >=163 keV, E(gamma)=208.4 keV) is one of the most promising RNs to be used in nuclear medicine, especially in metabolic radiotherapy of cancer of small dimensions. The production of Lu-177g is carried out mainly in thermal nuclear reactor in two different ways by using targets of Lu or Yb: in the first case Lu-177(m+g) is produced in carrier-added (CA) form by (n,gamma) reaction on enriched target of Lu-176 leading to a lower specific activity AS compared to the theoretical carrier-free value AS(CF) = 4.05 GBq/microg, while in the second case Lu-177g is produced in no-carrier-added (NCA) form by (n,gamma) reaction on enriched target of Yb-176 followed by negatron decay leading, after selective separation of Lu from Yb, to a higher AS than in the previous case. This latter case shows no evidence of production of the long-lived impurity Lu-177m. As an alternative method is to produce Lu-177 by the deuteron activation of natural Yb or enriched in Yb-176 targets. In this case , with the following routs of interest are the indirect reaction Yb-176(d,p)Yb-177 that decays by negatron emission to Lu-177g and a much smaller contribution of the direct reaction Yb-176(d,n)Lu-177(g+m).
Lu-177 ; radionuclide production ; cyclotron ; metabolic radiotherapy ; nuclear medicine
Settore FIS/07 - Fisica Applicata(Beni Culturali, Ambientali, Biol.e Medicin)
Settore CHIM/03 - Chimica Generale e Inorganica
2009
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/151981
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact